share_log

Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15

Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15

拉登堡塔尔曼以买入评级启动对Peak Bio的报道,宣布目标股价为15美元
Benzinga Real-time News ·  2022/11/04 07:24

Ladenburg Thalmann analyst Ahu Demir initiates coverage on Peak Bio (NASDAQ:PKBO) with a Buy rating and announces Price Target of $15.

拉登堡·塔尔曼分析师阿胡·德米尔以买入评级开始对Peak Bio(纳斯达克股票代码:PKBO)进行报道,并宣布目标股价为15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发